Levocetirizine Dihydrochloride Tablet
Product Images NDC 72789-023

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levocetirizine Dihydrochloride (NDC 72789-023). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image (72789023)

Image (72789023)
This is a medication used for treating allergies or hives. Each tablet contains 5 mg of Levocetirizine Dihydrochloride. The medication may cause drowsiness, so it is important to be cautious while driving or performing tasks that require mental alertness. The bottle contains 30 tablets and the recommended dosage may vary depending on the person. This medication is not suitable for children and must be kept out of their reach. If any side effects occur, contact your doctor for medical advice or report it to the FDA. The medication is manufactured by PD-Rx Pharmaceuticals Incorporated and the lot number is 120866 with an expiry date of February 2022. The tablets are white, round and scored with 181 H marking. Packaging also includes a GNTIN number and other identifying information.*
FDA Label Image

Levocitirizinestructure (Levocitirizinestructure)

Levocitirizinestructure (Levocitirizinestructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.